Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Explainer-How the Merck/Moderna Cancer Vaccine Works and Possible Barriers to Wide Use

Interim trial data showed the vaccine-Keytruda combination cut melanoma recurrence and spread, while more studies are underway in several other cancers.

Summary by WTVB
By Mariam Sunny and Christy Santhosh Aug 25 (Reuters) - The personalized cancer vaccine being developed by Moderna and Merck has boosted hopes that mRNA technology could open up a new avenue of treatment, but the available evidence is still limited. In...

8 Articles

A personalized cancer vaccine developed by Moderna and Merck showed promising results by reducing the risk of recurrence of melanoma.

·Mexico City, Mexico
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 80% of the sources are Center
80% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

ScienceBlog.com broke the news on Tuesday, August 25, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal